The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(1-benzoyl-1H-indol-5-yl)-5-chloro-2-hydroxybenzamide ID: ALA4744704
PubChem CID: 162648350
Max Phase: Preclinical
Molecular Formula: C22H15ClN2O3
Molecular Weight: 390.83
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1ccc2c(ccn2C(=O)c2ccccc2)c1)c1cc(Cl)ccc1O
Standard InChI: InChI=1S/C22H15ClN2O3/c23-16-6-9-20(26)18(13-16)21(27)24-17-7-8-19-15(12-17)10-11-25(19)22(28)14-4-2-1-3-5-14/h1-13,26H,(H,24,27)
Standard InChI Key: WIANGICMDAATEW-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
0.4773 -4.2799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4762 -5.0994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1842 -5.5084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8939 -5.0990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8911 -4.2763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1825 -3.8710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1796 -3.0540 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1820 -6.3238 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.5972 -3.8650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3065 -4.2710 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5942 -3.0479 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0126 -3.8597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7203 -4.2690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7091 -2.6346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0064 -3.0476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4234 -3.0404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4254 -3.8553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2011 -4.1053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6785 -3.4447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1978 -2.7867 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4484 -2.0089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2473 -1.8369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9000 -1.4029 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7969 -2.4482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5952 -2.2768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8464 -1.4983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2933 -0.8910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4971 -1.0655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
3 8 1 0
5 9 1 0
9 10 1 0
9 11 2 0
10 12 1 0
12 13 2 0
13 17 1 0
16 14 1 0
14 15 2 0
15 12 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 16 1 0
20 21 1 0
21 22 1 0
21 23 2 0
22 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 390.83Molecular Weight (Monoisotopic): 390.0771AlogP: 4.94#Rotatable Bonds: 3Polar Surface Area: 71.33Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.39CX Basic pKa: ┄CX LogP: 4.64CX LogD: 4.34Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.52Np Likeness Score: -1.33
References 1. Chen X,Wang G,Mohammed Alsayed AM,Du Z,Lu Liu null,Ma Y,Liu P,Zhang Q,Chen X,Chen W,Ye F,Zheng X,Liu Z. (2021) Synthesis and biological evaluation of novel N-substituted benzamides as anti-migration agents for treatment of osteosarcoma., 214 [PMID:33530028 ] [10.1016/j.ejmech.2021.113203 ]